Hiroo Ishida
Yokohama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
Polymorphisms of FGFR Pathway-related Factors and Capecitabine-induced Hand-foot Syndrome in Japanese Patients With Colorectal Cancer.
Journal: Anticancer research
Published: November 20, 2025
Efficacy and safety of necitumumab and pembrolizumab combination therapy in advanced non-small-cell lung cancer with ≥50% PD-L1 expression: A nonrandomized phase II trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 31, 2025
Association of IL12RB2, RORC, and class II HLA polymorphisms with severe erythema multiforme of regorafenib in Japanese patients with colorectal cancer.
Journal: Cancer chemotherapy and pharmacology
Published: June 11, 2025
ABCC4 polymorphism indirectly reduces systemic exposure to a capecitabine metabolite 5'-deoxy-5-fluorouridine in Japanese subjects.
Journal: British journal of clinical pharmacology
Published: September 13, 2024
Association Between ABCC2 -24C>T and Nab-Paclitaxel-induced Peripheral Neuropathy in Japanese Patients With Pancreatic Cancer.
Journal: Anticancer research
Published: August 30, 2024
Post-recurrence survival in patients with stage III gastric cancer who received adjuvant chemotherapy; post-hoc analysis of the JACCRO GC-07 study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 22, 2024
Cost-effectiveness analysis of first line pembrolizumab monotherapy for high programmed cell death ligand 1 expressed, advanced non-small cell lung cancer in Japan.
Journal: International journal of clinical pharmacy
Published: April 15, 2024
Association of VEGFA and CCL4L2 polymorphisms with hand-foot skin reaction and survival of regorafenib in Japanese patients with colorectal cancer.
Journal: Cancer chemotherapy and pharmacology
Published: December 04, 2023
A polymorphism in ABCA2 is associated with neutropenia induced by capecitabine in Japanese patients with colorectal cancer.
Journal: Cancer chemotherapy and pharmacology
Published: June 05, 2023
Associations of HLA-C*01:02 and HLA-B*46:01 with regorafenib-induced erythema multiforme in Japanese patients with metastatic colorectal cancer.
Journal: Clinical and translational science
Published: May 28, 2023
A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study): primary analysis.
Journal: Therapeutic advances in medical oncology
Published: August 10, 2022
Pharmacokinetics of gefitinib in elderly patients with EGFR-mutated advanced non-small cell lung cancer: a prospective study.
Journal: BMC pulmonary medicine
Published: April 18, 2022
Last Updated: 09/26/2026